Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
Healthcare
$18.98 -0.05%
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
52W Low $15.35High $20.30
Volume 0.37M
Average 0.43M
ODTX Pre-Tax Margin
Income before tax as a percentage of revenue.
No reported Pre-Tax Margin figures are available to summarize.
Pre-Tax Margin history
Percent of revenue · from the income statement
No Pre-Tax Margin data reported for this period type.
Pre-Tax Margin vs competitors
How ODTX compares with its peers on the latest reported figures
ODTX Competitors Peer median
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 29.9% | +4.2 pp | +198.3 pp | |
| LTM Mar 2026 | -11.5% | +114.2 pp | +1245.5 pp | |
| LTM Sep 2026 | -291.6% | — | — | |
| LTM Mar 2026 | -832.6% | -100.2 pp | -537.5 pp | |
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | -5957.2% | -4780.0 pp | — |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — |
ORKAOruka Therapeutics, Inc. | FY2025 | — | — | — |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | FY2024 | — | — | — |
| FY2025 | — | — | — | |
| Peer median (excluding ODTX) | -291.6% | -48.0 pp | +198.3 pp | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Currency unavailable
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.